Is 340B good for the healthcare system? Takeaways from an MHE/Drug Topics webinar

Author(s)Peter Wehrwein, Managing Editor, Denise Myshko

Industry leaders Tom Kraus and Shawn Gremminger debated 340B’s value during a Managed Healthcare Executive/Drug Topics webinar. Panelists clashed over transparency, safety-net eligibility, and how 340B savings should be spent.

Does the 340B program help hospitals provide care and other services to low-income patients? Or has the program grown beyond what was initially intended, with undeserving institutions taking advantage of it?